Article
Pharmacogenetics of Inflammatory Bowel Disease
11 Dec 2020
Abstract excerpt
Patients with inflammatory bowel disease (IBD) show large variability in disease course, and also treatment response. The variability in treatment response has led to many initiatives in search of genetic markers to optimize treatment and avoid severe side effects. This has been very successful for thiopurines, one of the drugs used to induce and maintain remission in IBD. However, for the newer treatment options...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
